Document Detail


Development of novel CXCR4-based therapeutics.
MedLine Citation:
PMID:  22283809     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Introduction: During embryogenesis, CXCR4, a chemokine receptor, and its ligand, stromal cell-derived factor-1 (SDF-1/CXCL12), are critically involved in the development of the hematopoietic, nerve and endothelial tissues by regulating tissue progenitor cell migration, homing and survival. In adult life, the CXCR4 axis serves as the key factor for stem and immune cell trafficking. More importantly, CXCR4-CXCL12 axis plays a critical role in HIV, stem cell mobilization, autoimmune diseases, cancer and tissue regeneration. Targeting the CXCR4-CXCL12 axis, therefore, is an attractive therapeutic approach in various diseases. Areas covered: In this review, we update current knowledge about CXCR4-CXCL12 biology, therapeutic approaches and therapeutic agents. The data presented was collected from http://www.ncbi.nlm.nih.gov/pubmed , http://clinicaltrials.gov/ , http://bloodjournal.hematologylibrary.org/ . Expert opinion: Development of CXCR4 antagonists with increased affinity, extended pharmacokinetics and/or pharmacodynamics and with the capacity to differentially target CXCR4 may lead to a development of novel therapeutics for HIV, cancer, tissue regeneration and stem cell collection.
Authors:
Amnon Peled; Ori Wald; Jan Burger
Related Documents :
3091439 - Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are ...
12190929 - The road ended up at stem cells.
16051689 - Hematopoietic stem cell trafficking in liver injury.
20800819 - Early t cell differentiation lessons from t-cell acute lymphoblastic leukemia.
17377529 - Cell tracing shows the contribution of the yolk sac to adult haematopoiesis.
18927479 - Roundabout 4 is expressed on hematopoietic stem cells and potentially involved in the n...
6189909 - Studies on the mechanism of natural killer cell-mediated cytotoxicity. iv. interferon-i...
10892719 - Controversies in cutaneous lymphomas.
9474749 - Stromal-conditioned medium synergizes with thrombopoietin in stimulating megakaryocytop...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-28
Journal Detail:
Title:  Expert opinion on investigational drugs     Volume:  -     ISSN:  1744-7658     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9434197     Medline TA:  Expert Opin Investig Drugs     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Hadassah Hebrew University Hospital , Goldyne Savad Institute of Gene Therapy , Jerusalem , Israel peled@hadassah.org.il.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Commentary: studies on binge-like ethanol drinking may help to identify the neurobiological mechanis...
Next Document:  Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds.